Urba WJ - Search Results

1

Retrospective analysis of stage I and II indolent lymphomas at the National Cancer Institute.

Lawrence TS, Urba WJ, Steinberg SM, Sundeen JT, Cossman J, Young RC, Glatstein E. Lawrence TS, et al. Among authors: urba wj. Int J Radiat Oncol Biol Phys. 1988 Mar;14(3):417-24. doi: 10.1016/0360-3016(88)90254-4. Int J Radiat Oncol Biol Phys. 1988. PMID: 2449414

2

Recent National Cancer Institute lymphoma trials of etoposide-containing combination chemotherapy.

Urba WJ, Wilson WH, Duffey PL, Wittes R, Chabner BA, Longo DL. Urba WJ, et al. Semin Oncol. 1992 Dec;19(6 Suppl 13):26-32. Semin Oncol. 1992. PMID: 1283467 Review.

3

Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.

Longo DL, Duffey PL, Young RC, Hubbard SM, Ihde DC, Glatstein E, Phares JC, Jaffe ES, Urba WJ, DeVita VT Jr. Longo DL, et al. Among authors: urba wj. J Clin Oncol. 1992 Feb;10(2):210-8. doi: 10.1200/JCO.1992.10.2.210. J Clin Oncol. 1992. PMID: 1732422

4

Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.

Longo DL, Glatstein E, Duffey PL, Young RC, Hubbard SM, Urba WJ, Wesley MN, Raubitschek A, Jaffe ES, Wiernik PH, et al. Longo DL, et al. Among authors: urba wj. J Clin Oncol. 1991 Jun;9(6):906-17. doi: 10.1200/JCO.1991.9.6.906. J Clin Oncol. 1991. PMID: 2033427 Clinical Trial.

5

Treatment of patients with aggressive lymphomas: an overview.

Urba WJ, Duffey PL, Longo DL. Urba WJ, et al. J Natl Cancer Inst Monogr. 1990;(10):29-37. J Natl Cancer Inst Monogr. 1990. PMID: 2189474 Review.

6

Refinement of lymphoma cytogenetics by the chromosome 18q21 major breakpoint region.

Lipford E, Wright JJ, Urba W, Whang-Peng J, Kirsch IR, Raffeld M, Cossman J, Longo DL, Bakhshi A, Korsmeyer SJ. Lipford E, et al. Blood. 1987 Dec;70(6):1816-23. Blood. 1987. PMID: 2823937 Free article.

7

Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinoma.

Sznol M, Clark JW, Smith JW 2nd, Steis RG, Urba WJ, Rubinstein LV, VanderMolen LA, Janik J, Sharfman WH, Fenton RG, et al. Sznol M, et al. Among authors: urba wj. J Natl Cancer Inst. 1992 Jun 17;84(12):929-37. doi: 10.1093/jnci/84.12.929. J Natl Cancer Inst. 1992. PMID: 1629914

8

Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment.

Curti BD, Urba WJ, Alvord WG, Janik JE, Smith JW 2nd, Madara K, Longo DL. Curti BD, et al. Among authors: urba wj. Cancer Res. 1993 May 15;53(10 Suppl):2204-7. Cancer Res. 1993. PMID: 8485703 Clinical Trial.

9

Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.

Longo DL, Duffey PL, Gribben JG, Jaffe ES, Curti BD, Gause BL, Janik JE, Braman VM, Esseltine D, Wilson WH, Kaufman D, Wittes RE, Nadler LM, Urba WJ. Longo DL, et al. Among authors: urba wj. Cancer J. 2000 May-Jun;6(3):146-50. Cancer J. 2000. PMID: 10882329 Clinical Trial.

10

Phase I evaluation of recombinant tumor necrosis factor given in combination with recombinant interferon-gamma.

Smith JW 2nd, Urba WJ, Clark JW, Longo DL, Farrell M, Creekmore SP, Conlon KC, Jaffe H, Steis RG. Smith JW 2nd, et al. Among authors: urba wj. J Immunother (1991). 1991 Oct;10(5):355-62. doi: 10.1097/00002371-199110000-00007. J Immunother (1991). 1991. PMID: 1790143 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters